Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests.
Diabetic patients receiving peritoneal dialysis have vast differences in glucose absorption, significantly affecting glycemic control. Measurement of glucose levels between dialysate exchanges does not adequately reflect these changes. By measuring glucose levels during the peak period of glucose absorption, as determined by a peritoneal equilibrium test, such differences can be measured and accounted for when determining doses of intraperitoneal insulin. In this report, 3 cases in which such an approach was applied are described.
Thorp
Micah L
ML
Lake Road Nephrology Center, Kaiser Permanente Kidney Program, Portland, OR, USA. Micahthorp@comcast.net
Wilks
Teresa S
TS
D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000097:blood / Q000628:therapy*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
D001786:Blood Glucose; D007328:Insulin